REFOCUS TIME:
Last few news events out takes: Houston, TX, Feb 17, 2010 (M2 PRESSWIRE via COMTEX) -- In December 2009 Healthcare of Today, Inc.announced the acquisition of Xenotis Pty Ltd. to its biotech division, the Australian-based producer of advanced human tissue engineering technology for $40M and now has been identified as one of the assets that will be included in the new bio-tech division of Guardian Angel Group (Pinsheets: GAGI).
"Xenotis is leading the world in advanced human tissue engineering. While many companies are interested in this fast-growing market, few have made the clear strides that Xenotis has. The company has working products and a strong distribution network in place around the globe. As we consider how to seamlessly integrate Xenotis into our biotech division, I think there is a particular dynamic to be enjoyed given our relationship with Regenetech, which is the world leader in advanced stem cell research technology," said Healthcare of Today CEO Henry Jan.
Houston, TX, Feb 18, 2010 (M2 PRESSWIRE via COMTEX) -- Guardian Angel Group Inc's (Pinsheets: GAGI) president John Gonzalez would like to express his appreciation for the ongoing patients and understanding of all involved with the merger as well as the shareholders of Guardian Angel Group Inc. Mr. Gonzalez stated today, " I am excited what this merger between our two companies represents to our shareholders current and in the future." Gonzalez concluded, "I never would have imagined that I would see a merger of this magnitude come together in my tenure while fitting so well to our overall business structure and management philosophies, we as the board of directors are doing our level best and will continue to keep everyone involved apprised of the details as they develop."
The company still believes that they are on schedule and urge all shareholders to visit the two company's websites for up to date information.
Houston, TX, Feb 22, 2010 (M2 PRESSWIRE via COMTEX) -- Guardian Angel Group Inc's (Pinsheets: GAGI) president John Gonzalez while chairing the board of directors for the last four months will be stepping down after the pending merger is complete. Mr. Gonzalez stated, "While I have extremely enjoyed my position on the board of directors it is now time for me to step aside for a new direction of growth and prosperity for the company and it's shareholders." Mr. Gonzales concluded, "I have been privy to the development's concerning the ongoing structure of the company's board of directors and new biotech division, I am excited what the future holds for the company's shareholders and our company's asset base. I believe our shareholders as well as the medical community will be impressed with the list of the new board members and our biotech division ongoing. I also believe that all involved will be equally impressed with the professionalism and leadership that Healthcare of Today Inc. brings to our future as a leader in the Medical Biotech industry."
